Immunosuppressive therapy and cancer risk in ocular inflammation patients: fresh evidence and more questions
Ophthalmology
.
2015 Feb;122(2):219-21.
doi: 10.1016/j.ophtha.2014.11.023.
Authors
Naira Khachatryan
1
,
John H Kempen
1
Affiliation
1
Philadelphia, Pennsylvania.
PMID:
25618424
DOI:
10.1016/j.ophtha.2014.11.023
No abstract available
Publication types
Editorial
Comment
MeSH terms
Female
Humans
Immunosuppressive Agents / adverse effects*
Male
Neoplasms / chemically induced*
Pemphigoid, Benign Mucous Membrane / drug therapy*
Scleritis / drug therapy*
Uveitis / drug therapy*
Substances
Immunosuppressive Agents
Grants and funding
R01 EY014943/EY/NEI NIH HHS/United States